Delivery Order SPE2DB24D2101-SPE2DB24FKFUS
Award Date
8/12/24
Potential Completion Date
8/13/24
Potential Value
$3.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,446,070 units of the BOOSTRIX TDAP vaccine syringe (0.5 ml). The firm-fixed-price contract is valued at $1,053.96 and has an ultimate completion date of November 18, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide 4,565,725,440 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL) at a firm fixed price of $24,001.40. The award has an ultimate completion date of September 10, 2024 and is not set aside for any specific business type. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BOOSTRIX TDAP vaccine syringes 0.5mL, with a ceiling value of $3,028.66 and a performance period through November 2024. The contract is a firm fixed-price arrangement and does not have any set-aside designations. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $1,021.76 firm-fixed price contract is for the supply of 4,565,913,991 units of the BOOSTRIX TDAP vaccine syringe 0.5 mL. The contract has an ultimate completion date of September 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP Vaccine Syringes. The contract has a ceiling value of $1,021.72 and an ultimate completion date of September 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not designated as a set-aside contract. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) held...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a vaccine product, with a ceiling value of $1,021.72 and a period of performance through September 16, 2024. This order is not subject to a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BOOSTRIX TDAP vaccine syringes. The contract is a firm-fixed-price, indefinite delivery vehicle valued at up to $12,654.00, with a period of performance through July 2024. There is no set-aside designation for this award. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor responsible for providing these critical medical supplies to support federal...
The U.S. Defense Logistics Agency (DLA) awarded a $25,778 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 4,564,306 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL). This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
This is a $3,699.02 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 0.5 mL Boostrix TDAP vaccine syringes. The contract has an ultimate completion date of August 7, 2024. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, for delivering a wide range of medical commodities to support...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Boostrix TDAP vaccine syringes. The award, valued at $1,723.92, has a completion date of September 23, 2024. As a delivery order, this award is part of a larger indefinite delivery contract (IDC) between AmerisourceBergen and the DLA, valued up to $999,999,999 through December 2025, for the delivery of a...